Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants

Author： Ehrenpreis Eli D Sifuentes Humberto Ehrenpreis Jamie E Smith Zachary L Marshall Mike L

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.11, Iss.2, 2012-03, pp. : 177-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

`Extreme Duplication' in the US FDA Adverse Events Reporting System Database

By Hauben Manfred Reich Lester DeMicco James Kim Katherine

Drug Safety, Vol. 30, Iss. 6, 2007-01 ,pp. : 551-554

Adis International

Access to resources Recommend Favorite

Adverse Events Reporting

By Adis International Limited

Clinical Drug Investigation, Vol. 27, Iss. 3, 2007-01 ,pp. : 225-225

Adis International

Access to resources Recommend Favorite

Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database: A Disproportionality Analysis

By Shamloo Behrooz K.

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 507-518

Adis International

Access to resources Recommend Favorite

Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System: Disposition of Events Identified and Impact on Product Safety Profiles

By Bailey Steven Singh Ajay Azadian Robert Huber Peter Blum Michael

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

By Wang Hsin-wei

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1117-1133

Adis International

Access to resources Recommend Favorite